Some Apple employees have become disillusioned with the group's culture, where some have thrived while others feel sidelined.Technologyread more
Biden has shown staying power at the top of a jammed Democratic field even as polling numbers for Sanders, Warren and Harris wax and wane.2020 Electionsread more
The FDIC on Tuesday votes to approve a five-agency revision of the post-crisis regulation known as the Volcker Rule.Financeread more
Stocks slipped on Tuesday as investors digested a sharp rebound from a strong sell-off last week.US Marketsread more
For investors still haunted by last week's monster sell-off, the market's comeback is set to last, according to J.P. Morgan's quant guru.Marketsread more
An under-the-radar hedge fund is ruling the industry with a nearly 30% return this year so far, and it's more than doubling its bet on gold.Marketsread more
The National Rifle Association is turning to old stock footage of Dana Loesch, their former spokeswoman, to rally supporters in the wake of the recent mass shootings and...Politicsread more
The move comes as Facebook continues to grapple with its privacy practices and lawmakers' scrutiny over how it uses personal data to display ads. But it will probably won't...Technologyread more
The launch follows a "preview" earlier this month that allowed only limited customers to apply.Technologyread more
"The hawks on the Fed are going to be gunning for no more rate cuts, which is obviously not what the market wants," says CNBC's Jim Cramer.Marketsread more
U.S. interest rates will keep falling and follow global interest rates all the way down to zero, hedge fund manager Kyle Bass said.Marketsread more
One of the banking world's leading deal-makers has said the timing of the U.S. Federal Reserve's first interest rate rise in six and half years will not stop firms eyeing merger and acquisitions this year.
Underlying factors such as wage inflation and companies' needs to divest some of their cash pile will continue to drive M&A activity, regardless of the Fed's strategy on rates, senior MD and global head of Blackstone Advisory Partners, John Studzinski told CNBC.
"I don't think it (a rate rise) will have a short-term impact at all, people are already building that in, whether it takes place fourth quarter or first quarter, the magnitude of that increase is probably less. I think the bigger issue is to first understand the magnitude of inflation, wage inflation, and the impact that has on any decision undertaken by the Fed," John Studzinski told CNBC.
The U.S. economy created 280,000 jobs in May, better than expected and likely confirming hopes that growth is back on track after a slow start to the year, according to data released on Friday. The jobs numbers are critical in that they will go a long way toward determining tightening policy from the Federal Reserve
After keeping short-term interest rates near zero for over six years, the U.S. central bank is looking for signs of not just job creation but also wage growth, a combination of which would indicate inflation is on a positive trajectory. After Friday's strong job's number, analysts are now saying a rate hike as early as September is back on the cards.
"M&A activity, for the reasons we have talked about already – the magnitude of cash, the need to generate growth and the strategic logic in five or six sectors is very compelling and I don't see that changing for the foreseeable future," he added.
Formerly a banker at Morgan Stanley and then at HSBC, Studzinski made his name on working on deals such as Unilever's successful $25 billion battle for Best Foods in 2000.
Speaking on the sectors that he was seeing most inquiries for M&A advice, Studzinski said the Technology, Media and Telecommunications (TMT) sector has had "very robust" inquiry and activity.
"The consumer space increasingly active and of course the healthcare space - healthcare broadly defined - pharmaceutical, equipment, services, the whole healthcare space undergoing a lot of scrutiny in terms of deals and just started to see the beginning of a lot of activity in chemicals," he said.
Global deal making so far in 2015 has reached $1.4 trillion, almost hitting 2007 levels according to recent data from Mergermarket, with seven deals above $20 billion seen so far this year, a vast increase compared to the four seen this time last year.
Deals in the pharmaceutical, medical and biotech space are at an all-time year-to-date high according to the group, with deals worth $45.2 billion to date, up over 75 percent compared to the same period in 2014.
"Rates are low now, but they are going to go up, but not so much that it's going to change the reason for a management team or a board to support a major strategic deal, given the amount of cash they have already on their balance sheets," Studzinski said.